Over 2,700 deaths reported due to Hepatitis-B in India in last five years: Centre
India has reported over 2,700 deaths due to Hepatitis B in the last five years. In 2024, as many as 607 deaths were reported. The highest number ...
Victory Capital Management Inc. Increases Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
Victory Capital Management Inc. boosted its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 52.8% during the ...
Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025Commercial launch in the PRC of generic nintedanib for the ...
Sarepta discloses patient death after gene therapy treatment
Sarepta Therapeutics said on Tuesday a young man has died due to acute liver failure after treatment with its gene therapy for a rare muscular dystrophy. Shares of the company plummeted more than 25% ...
Sarepta: Disclosure Of An Elevidys Patient's Death Creates Market Uncertainty
Sarepta Therapeutics shares dropped 20% after a patient's death raises Elevidys safety concerns. Read why I am downgrading ...
pharmaphorum18h
GSK plans phase 3 for hepatitis B drug bepirovirsen, despite efficacy drop
GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...